Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:01255'
s FCF Margin % Range Over the Past 10 Years
Min: -20.83 Med: 0.75 Max: 13.73
Current: -17.02
During the past 13 years, the highest FCF Margin % of TATA Health International Holdings was 13.73%. The lowest was -20.83%. And the median was 0.75%.
HKSE:01255's FCF Margin % is ranked worse than 86.49% of 1044
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 2.325
vs HKSE:01255: -17.02
TATA Health International Holdings FCF Margin % Related Terms
TATA Health International Holdings FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings FCF Margin % Chart
HKSE:01255 vs NKE, DECK, ONON: FCF Margin % Comparison
For the Footwear & Accessories subindustry, TATA Health International Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TATA Health International Holdings FCF Margin % vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, TATA Health International Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where TATA Health International Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings (HKSE:01255) has a FCF Margin % of -4.99% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TATA Health International Holdings and its competitors. According to the industry distribution chart, TATA Health International Holdings ranks #903 out of 1044 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 86.5%.
Is TATA Health International Holdings' FCF Margin % too high?
TATA Health International Holdings' current FCF Margin % is -4.99%. Based on the distribution chart, TATA Health International Holdings ranks #903 out of 1044 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, TATA Health International Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TATA Health International Holdings' FCF Margin % compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, TATA Health International Holdings ranks #903 out of 1044 companies for FCF Margin %. This places TATA Health International Holdings in the lower half of its industry. The industry median FCF Margin % is 2.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Manufacturing - Apparel & Accessories company?
The median FCF Margin % among Manufacturing - Apparel & Accessories companies is 2.33, based on 1,044 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TATA Health International Holdings and its competitors. For the Manufacturing - Apparel & Accessories industry, the median FCF Margin % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TATA Health International Holdings's current FCF Margin % is -4.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TATA Health International Holdings stock overvalued right now?
Based on GuruFocus' analysis, TATA Health International Holdings (HKSE:01255) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$2.18 — trading 890.9% above its estimated fair value. The current FCF Margin % is -4.99%. TATA Health International Holdings' overall GF Score™ is 22/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For TATA Health International Holdings (HKSE:01255), the current FCF Margin % is -4.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?
Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued.
The current stock price of HK$2.18 is trading 890.9% above its estimated GF Value™ of HK$0.22.
GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:01255:
FCF Margin %: -4.99%
GF Value™: HK$0.22 vs. price of HK$2.18 (890.9% above fair value)
No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TATA Health International Holdings Business Description
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score
Get the complete analysis for HKSE:01255
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01255 has been successfully added to your 
